Daivobet Dosage & Drug Information

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Core Prescribing Info

Contents

Calcipotriol monohydrate, betamethasone dipropionate

Indications/Uses

Oint: Initial topical treatment of stable plaque psoriasis vulgaris amenable to topical therapy. Gel: Scalp psoriasis & non-scalp plaque psoriasis vulgaris.

Dosage/Direction for Use

Apply to affected areas once daily. Max daily dose: 15 g. Max wkly dose: 100 g. Max treated area: 30% of BSA. Oint Use for 4 wk. Gel Scalp areas 1-4 g daily for 4 wk. Non-scalp areas Use for 8 wk.

Contraindications

Hypersensitivity. Disorders of Ca metabolism. Viral (eg, herpes or varicella) skin lesions, fungal or bacterial skin infections, parasitic infections, skin manifestations in relation to TB, perioral dermatitis, atrophic skin, striae atrophicae, fragility of skin veins, ichthyosis, acne vulgaris, acne rosacea, rosacea, ulcers, wounds, perianal & genital pruritus; erythrodermic, exfoliative & pustular psoriasis.

MIMS Class

Psoriasis, Seborrhea & Ichthyosis Preparations

ATC Classification

D05AX52 - calcipotriol, combinations ; Belongs to the class of other antipsoriatics for topical use.

Regulatory Classification

POM

Presentation/Packing

Form

Daivobet oint

Packing/Price

1's

Form

Daivobet gel

Packing/Price

1's

Daivobet

betamethasone + calcipotriol

Manufacturer:

LEO Pharma